Influenza Vaccines Market Expected To Grow At 7.8% CAGR Through 2030: What Businesses Need To Know
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Influenza Vaccines Market CAGR Outlook And Future Development
The influenza vaccines market has experienced substantial expansion in recent years. This market is projected to increase from $9.04 billion in 2025 to $9.71 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.4%. Historically, this expansion resulted from factors such as the increasing prevalence of seasonal influenza, a limited public awareness during the early 2000s, the widespread use of trivalent vaccines, insufficient global manufacturing capacity, and a dependence on conventional egg-based production methods.
Projections indicate significant expansion for the influenza vaccines market size in the coming years. This market is projected to reach $13.13 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.8%. This anticipated growth during the forecast period can be primarily linked to the wider acceptance of quadrivalent vaccines, the broadening scope of precision medicine approaches, an increase in governmental vaccination programs, advancements in cell-based and recombinant vaccine technologies, and improvements in cold chain and distribution networks. Key trends anticipated during this period encompass the refinement of seasonal vaccine formulations, the growth of pediatric immunization initiatives, a rise in government-backed flu vaccination drives, the incorporation of new adjuvants to boost immunogenicity, and an expansion of vaccine delivery options in home and outpatient settings.
Get A Free Sample Report With In-Depth Market Insights:
Influenza Vaccines Market Growth Backed By Core Demand Fundamentals
The influenza vaccine market is anticipated to expand due to increasing seasonal influenza occurrences. Seasonal influenza is defined as a respiratory illness caused by influenza viruses that commonly circulate and lead to infections during particular times of the year, typically in colder months. This increase is a result of antigenic drift, population susceptibility, various environmental factors, incomplete vaccine coverage, and the absence of universal vaccination. Influenza vaccines play a crucial role in lowering the incidences of seasonal influenza by providing immunization against the circulating strains of the virus. For instance, in November 2023, the Centers for Disease Control and Prevention (CDC) reported that the 2022-2023 flu season saw approximately 31 million flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospitalizations, and 21,000 flu-related deaths. Therefore, the rising incidences of seasonal influenza are directly fueling the growth of the influenza vaccines market.
Influenza Vaccines Market Segment Analysis: What Are The Core Market Categories?
The influenza vaccines market covered in this report is segmented –
1) By Vaccine Type: Inactivated, Live Attenuated
2) By Valency: Quadrivalent, Trivalent
3) By Route Of Administration: Injection, Nasal Spray
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels
Subsegments:
1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)
2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)
Influenza Vaccines Market Growth Trends Reshaping The Competitive Landscape
Major companies in the influenza vaccine market are adopting advanced product innovations, such as quadrivalent seasonal influenza vaccines, to strengthen their respiratory vaccine franchise and financial profile. A quadrivalent seasonal influenza vaccine is engineered to protect against four different flu viruses, specifically two influenza A viruses and two influenza B viruses. For instance, in September 2023, Clover Biopharmaceuticals Ltd., a biotechnology company based in China, launched AdimFlu-S (QIS), a quadrivalent seasonal influenza vaccine. This vaccine represents the sole imported quadrivalent seasonal influenza vaccine approved for use in individuals aged three years and older in China. The quadrivalent composition of the vaccine improves its capability to achieve high vaccine effectiveness, irrespective of which influenza B strain becomes seasonally prevalent, when compared to trivalent options.
Influenza Vaccines Market Top Companies Driving Competitive Growth
Major companies operating in the influenza vaccines market are Pfizer Inc., Merck & Co Inc., Sanofi-Aventis LLC, GlaxoSmithKline plc, Serum Institute of India Private Limited, Seqirus Inc., CSL Limited, Daiichi Sankyo Company Limited, Moderna Inc., Novavax AB, Bharat Biotech International Limited, Valneva SE, Shionogi & Co Ltd., Sinovac Biotech Co Ltd., Walvax Biotechnology Co Ltd., Hualan Biological Engineering Inc., China National Pharmaceutical Group Corporation, Green Cross Corporation, Mitsubishi Tanabe Pharma Corporation, Osivax, Vaxess Technologies Inc., Gamma Vaccines Pty Ltd
View The Full Influenza Vaccines Market Report:
Influenza Vaccines Market Geographic Spread And Regional Opportunities
North America was the largest region in the influenza vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
